Health Catalyst (HCAT) Shares Outstanding (2018 - 2026)

Health Catalyst (HCAT) has reported Shares Outstanding (Entity) for 9 consecutive years, with $74.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 6.15% year-over-year to $74.7 million; the trailing twelve-month figure through Jun 2026 stood at $74.7 million (up 6.15% YoY), and the FY2025 full-year result was $72.1 million, up 12.63% from the prior year.
• Shares Outstanding (Entity) climbed to $74.7 million in Q2 2026 per HCAT's latest filing, from $73.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $74.7 million in Q2 2026 and bottomed at $53.9 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $62.4 million across 5 years, with a median of $59.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) gained 21.29% in 2022, then increased 4.1% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $55.8 million in 2022, then grew by 4.96% to $58.5 million in 2023, then advanced by 9.42% to $64.0 million in 2024, then grew by 12.63% to $72.1 million in 2025, then gained by 3.56% to $74.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $74.7 million, $73.9 million, and $72.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.